Tectonic Therapeutic | AVRO - Interest Income

Stock Price
29.07
Daily Change
-0.91 -3.04%
Monthly
-14.50%
Yearly
98.16%
Q2 Forecast
29.60

Tectonic Therapeutic reported $1.74M in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
Alnylam Pharmaceuticals USD 28.68M 1.19M Sep/2025
Celltrion KRW 676.66M 6.85B Jun/2025
Dianthus Therapeutics USD 3.66M 255K Sep/2025
Gilead Sciences USD 88M 15M Sep/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Kangmei Pharma CNY 1.81M 2.5M Jun/2025
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
MacroGenics USD 1.53M 114K Sep/2025
Medical Developments International AUD 174K 31K Dec/2024
Pfizer USD 0.62 156M Sep/2025
Pharma Mar EUR 1.63M 3.17M Dec/2025
Qiagen NV USD 15.07M 1.21M Sep/2025
Sanofi EUR 114M 38M Sep/2025
Sarepta Therapeutics USD 8.38M 1.24M Sep/2025
Sartorius EUR 54.9M 77.1M Mar/2025
Takeda JPY 87.87B 43.48B Dec/2025
Tilray USD 12.83M 20.19M May/2024
Zhangzhou Pientzehuang Pharmaceutical CNY 6.65M 4.01M Jun/2025